Emilio Mola-Martin
La Paz, MD, Spain
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 53 publications
Erratum corrige: "Efficacy of tocilizumab monotherapy after response to combined tocilizumab and methotrexate in patients with rheumatoid arthritis: the randomised JUST-ACT study". J.L. Pablos et al.
Journal: Clinical and experimental rheumatology
Published: May 27, 2020
Circulating CD19+CD24hiCD38hi regulatory B cells as biomarkers of response to methotrexate in early rheumatoid arthritis.
Journal: Rheumatology (Oxford, England)
Published: January 10, 2020
Reducing or Maintaining the Dose of Subcutaneous Tocilizumab in Patients With Rheumatoid Arthritis in Clinical Remission: A Randomized, Open-Label Trial.
Journal: Arthritis & rheumatology (Hoboken, N.J.)
Published: October 11, 2018
Induction of sustained remission in early inflammatory arthritis with the combination of infliximab plus methotrexate: the DINORA trial.
Journal: Arthritis research & therapy
Published: April 16, 2018
Efficacy of tocilizumab monotherapy after response to combined tocilizumab and methotrexate in patients with rheumatoid arthritis: the randomised JUST-ACT study.
Journal: Clinical and experimental rheumatology
Published: March 20, 2018
Color Doppler and spectral Doppler ultrasound detection of active sacroiliitis in spondyloarthritis compared to physical examination as gold standard.
Journal: Rheumatology international
Published: March 08, 2017
Increased frequency of circulating CD19+CD24hiCD38hi B cells with regulatory capacity in patients with Ankylosing spondylitis (AS) naïve for biological agents.
Journal: PloS one
Published: January 20, 2017
Prevalence of comorbidities in rheumatoid arthritis and evaluation of their monitoring in clinical practice: the spanish cohort of the COMORA study.
Journal: Reumatologia clinica
Published: January 03, 2017
Ultrasound sensitivity to changes in gout: a longitudinal study after two years of treatment.
Journal: Clinical and experimental rheumatology
Published: October 11, 2016
Patients' and rheumatologists' preferences for the attributes of biological agents used in the treatment of rheumatic diseases in Spain.
Journal: Patient preference and adherence
Published: July 07, 2016
Adaptation of the osteoarthritis-specific quality of life scale (the OAQoL) for use in Germany, Hungary, Italy, Spain and Turkey.
Journal: Rheumatology international
Published: June 08, 2016
The Minimum Clinically Important Improvement and Patient-acceptable Symptom State in the BASDAI and BASFI for Patients with Ankylosing Spondylitis.
Journal: The Journal of rheumatology
Published: May 17, 2016
Last Updated: 09/26/2026